TY - JOUR
T1 - Catatonia
T2 - Back to the future of the neuropsychiatric syndrome
AU - Cuevas-Esteban, Jorge
AU - Sanagustin, David
AU - Iglesias-González, María
N1 - Publisher Copyright:
© 2021 Elsevier España, S.L.U.
PY - 2022/4/22
Y1 - 2022/4/22
N2 - Catatonia is an undertreated and underdiagnosed neuropsychiatric syndrome whose prognosis is benign if treated early, thus avoiding possible complications and compromising the health of patients. The latest epidemiological studies indicate a prevalence of catatonia of 9.2%, being frequent in medical pathologies (especially neurological ones), as well as in psychiatric pathologies. The use of validated scales is recommended for its diagnosis, to be able to measure the severity and response to treatment. Once catatonia has been identified, it is necessary to perform a protocolized diagnostic study of the underlying aetiology («Catatonia Workup»). Treatment of choice is benzodiazepines and electroconvulsive therapy. In recent years, new therapeutic alternatives such as non-invasive transcranial magnetic stimulation have emerged. In this review we propose several initiatives to promote the dissemination and knowledge of catatonia in the clinical setting.
AB - Catatonia is an undertreated and underdiagnosed neuropsychiatric syndrome whose prognosis is benign if treated early, thus avoiding possible complications and compromising the health of patients. The latest epidemiological studies indicate a prevalence of catatonia of 9.2%, being frequent in medical pathologies (especially neurological ones), as well as in psychiatric pathologies. The use of validated scales is recommended for its diagnosis, to be able to measure the severity and response to treatment. Once catatonia has been identified, it is necessary to perform a protocolized diagnostic study of the underlying aetiology («Catatonia Workup»). Treatment of choice is benzodiazepines and electroconvulsive therapy. In recent years, new therapeutic alternatives such as non-invasive transcranial magnetic stimulation have emerged. In this review we propose several initiatives to promote the dissemination and knowledge of catatonia in the clinical setting.
KW - Catatonia
KW - COVID-19
KW - Delirium
KW - ECT
KW - Lorazepam challenge test
KW - Neuropsychiatry
UR - http://www.scopus.com/inward/record.url?scp=85121289691&partnerID=8YFLogxK
U2 - 10.1016/j.medcli.2021.10.015
DO - 10.1016/j.medcli.2021.10.015
M3 - Review article
C2 - 34924197
AN - SCOPUS:85121289691
SN - 0025-7753
VL - 158
SP - 369
EP - 377
JO - Medicina clinica
JF - Medicina clinica
IS - 8
ER -